Zapping away chemo pain: new device trial offers hope

NCT ID NCT07151963

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a non-invasive brain stimulation technique called prolonged continuous theta burst stimulation (pcTBS) to relieve nerve pain caused by chemotherapy in breast cancer patients. Forty women will receive either pcTBS or standard repetitive transcranial magnetic stimulation (rTMS) in a crossover design. The goal is to see which method better reduces pain, depression, and anxiety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

prolonged continuous theta burst stimulation (pcTBS) device

What this could lead to

If it works, this could offer a non-drug way to reduce nerve pain and improve mood in breast cancer survivors with chemotherapy side effects.

What could go wrong

This is a small, early-stage crossover trial with only 40 people. The effect may be modest or not last, and results may not apply to all cancer types.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm chemotherapy-induced neuropathy female breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Taipei Tzu Chi Hospital

    New Taipei City, Taiwan